Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis
A. Didier(Hôpital Larrey), Michel Mélac(Stallergenes Greer (France)), Olivier Beaumont(Stallergenes Greer (France)), Friedrich Horak(University Clinic of Traumatology), Hans‐Jørgen Malling(Gentofte Hospital), A. Montagut, C. André(Service de Santé de la Jeunesse), Siegfried Jäger, Margitta Worm(Charité - Universitätsmedizin Berlin)
Cited by 485
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
|Allergy|2014|1.4k
World Allergy Organization Anaphylaxis Guidance 2020
|World Allergy Organization Journal|2020|1.1k